|
![]() |
|||||||||||
|
![]() |
|
Physicians
who meet qualifying criteria can now prescribe medication for treatment
of opioid addiction, thanks to recent US legislation |
|
About Opioid Dependence Estimates vary widely, but in 1996 government sources reported that as many as 2.9 million US residents had used heroin in their lifetimes, and approximately 660,000 had used it in the previous year. Heroin addiction affects people in a wide variety of communities and in all walks of life. However, data show that only about 100,000 are in treatment, in part because of limited access to treatment centers. The estimated cost to society of heroin addiction is about $20 billion annually. Treatment programs are an effective means of reducing opioid use and helping addicts become more productive citizens. The human toll of untreated heroin addiction is difficult to calculate, but in financial terms, the cost to society has been estimated at approximately $20 billion per year. |

|
Dependence as a Brain Disease Currently, it is recognized that chronic drug use can produce lasting changes in brain function and chemistry. Prolonged drug use can modify brain structure and function in fundamental ways that continue even after the patient stops taking drugs. As a chronic brain disease, then, it is fitting that addiction be managed like other chronic illnesses, such as diabetes and hypertension. The Drug Addiction Treatment Act of 2000 has laid the groundwork to make this prospect a practical reality. The Act gives qualifying physicians the ability both to treat opioid dependence and to monitor patient compliance safely and conveniently in the office. Physicians interested in offering these services to their patients must submit a notification to the Secretary of Health and Human Services. |